Efficacy of supplemental oxygen in reducing the need for laser or intravitreal bevacizumab in preterm infants with stage 2 retinopathy of prematurity
BMC Ophthalmol. 2024 May 24;24(1):220. doi: 10.1186/s12886-024-03483-w. ABSTRACT BACKGROUND: Retinopathy of prematurity (ROP) is a disease that affects preterm infants born younger than 30 weeks …